DUBLIN, August 22, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Cardiac Markers" report to their offering.

Biomarkers are biological or biochemical molecules, or genetic changes, or other characteristics that can be measured, and that indicate or predict a condition, risk, or likely response. Biomarkers can be used for a range of diagnostic applications including predicting disease risk, diagnosis, predicting prognosis, identifying appropriate therapy for an individual, monitoring disease or for return of a disease, and other applications. With the incidence of cardiovascular disease increasing greatly, cardiac markers are in huge demand.

Physicians use cardiac markers (CK-MB, troponin I, troponin T, myoglobin, brain natriuretic peptide (BNP), proBNP, high sensitive C-reactive protein (hsCRP), and homocysteine) and cardiovascular biomarkers in two ways: acute care to diagnose a cardiac event in a hospital emergency room (acute care) or chronic care to evaluate the risk of a cardiovascular event occurring and to monitor patients with a cardiovascular disease. The traditional markers CK-MB, troponin and myoglobin - were used in acute care and tests such as cholesterol were used to evaluate risk.

Cardiac Markers reviews the progression of cardiac diagnostic technologies and notes some trends in test strategies as well, including cardiac risk, genetics and cardiovascular disease, acute myocardial infarction and acute coronary syndrome, heart failure, lipid disorders, and ACP coronary heart disease screening.

There are currently a number of companies developing or marketing cardiac markers and cardiovascular biomarkers.

Key Topics Covered:

ONE: EXECUTIVE SUMMARY

TWO: INTRODUCTION

Overview

Cardiac Risk

Genetics and Cardiovascular Disease

Acute Myocardial Infarction and Acute Coronary Syndrome

Heart Failure

Lipid Disorders

ACP Coronary Heart Disease Screening

THREE: MARKET ANALYSIS

FOUR: COMPANY PROFILES

Abbott Laboratories

ALPCO

ARUP Laboratories

Axis-Shield Diagnostics, Ltd. (An Alere Company)

Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)

bioMérieux SA

CardioDx, Inc.

CardioGenics Holdings Inc.

Gamma Therapeutics, Inc.

Ortho-Clinical Diagnostics

Quest Diagnostics

Randox Laboratories Ltd.

RENESE UG

Roche

Tosoh Corporation

Tosoh Bioscience, Inc.

Recent Revenue History

For more information about this report visit http://www.researchandmarkets.com/research/ph3pwf/cardiac_markers

Related Topics: Biomarkers

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

Related Links

http://www.researchandmarkets.com

SOURCE Research and Markets